• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    State of the Industry Series (Part 1): FDA Restructuring and FTC Activity

    State of the Industry Part 2: Supplement Access, Safety, and CBD

    State of the Industry Part 3: Communication, Education, and Trust

    State of the Industry Part 4: Advanced/Advancing Technologies and Research

    State of the Industry Part 5: Advocating Best Practices
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto

    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier
    Exclusives
    Top Companies
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier

    Tocotrienol Supplementation May Aid Liver Function in Diabetes, MASL Patients

    Euromed Receives EcoVadis Platinum Medal for ESG Efforts

    State of the Industry Part 2: Supplement Access, Safety, and CBD
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional

    Kyowa Hakko Publishes First Report on Global Health, Sustainability Impact
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier

    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional

    Gencor’s PEA Ingredient Levagen+ May Offer Allergy Relief
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    RT Specialty

    Kaneka Nutrients

    KLK OLEO

    Xsto Solutions

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    RT Specialty

    Kaneka Nutrients

    KLK OLEO

    Xsto Solutions

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Top Companies
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Political Disruption Presents Opportunity for Industry

    How can the regulatory framework be improved in order to benefit business and consumers?

    Political Disruption Presents  Opportunity for Industry
    Todd Harrison, Venable04.03.17
    The U.S. election in November was certainly a surprise and ended one of the most controversial and disruptive elections in recent memory. The aftermath has been even more disruptive. Indeed, we have rarely seen a president so committed to being disruptive, and if the first three months of the Trump presidency are any indication, these trends will continue.

    Having the federal bureaucracy shaken up may or may not be good news to individuals or companies, but there is little doubt that disruption can either be positive or negative. Certainly, overly burdensome or nonsensical regulatory schemes are of themselves disruptive, especially if they deny access to products that promote overall health and well-being. In this regard, the present regulatory structure for dietary supplements and topical products is disruptive to the overall health and well-being of consumers in the U.S. 

    With regard to dietary supplements, the passage of the Dietary Supplement Health and Education Act (DSHEA) was considered disruptive legislation that tied the hands of the FDA. This myth persists today. The reality, however, is that over the last 22-plus years, this legislation has become more of a negative disruption by creating a construct that has left very few barriers of entry, stymied innovation—as FDA has learned it has considerable power under DSHEA—and left consumers with less information regarding how to better their overall health.

    Even worse, it creates a situation where it compels company lawyers to push the limits of credulity of the medical food category. Seriously, does anyone believe that individuals with osteoarthritis have a unique nutritional need for polyphenols? Does anyone earnestly believe “helps reduce the appearance of wrinkles” is any different than simply stating “helps reduces wrinkles”? Furthermore, does the claim “helps support normal blood sugar levels,” rather than “helps support already normal blood sugar levels,” make any sense? Does anyone believe that a simple change in the manufacturing method causes a pre-DSHEA dietary ingredient to, suddenly, become a “new” dietary ingredient? Or that changing a standardization level so the dietary supplement can be taken in one large pill, rather than one small pill, cause that ingredient to become a new dietary ingredient?

    Yet, this is exactly what the present regulatory framework does. Does anyone seriously believe that after 22 years, FDA can effectively determine what was on the market prior to Oct. 14, 1994 when documents were stored in boxes and not on computer networks? Should any regulator be able to ask for all the information substantiating a claim and then simply state “our experts disagree” and attempt to force a consent judgment down a company’s throat, because the company cannot make a solid evaluation of the regulator’s evidence? Yet, that is the FTC and state investigatory practice. They take all the information in and the target company gets no feedback. Simply stated, we have a disruptive regulatory state in the natural products industry. I will spare everyone my diatribe on class action lawsuits.  

    Dysfunctional Framework
    These are just a few of the points that a negative disruptive regulatory framework brings to us. Indeed, one could say to be careful what you ask for because you may very well get it. Well, 22-plus years later we have a dysfunctional regulatory framework that wreaks havoc in the marketplace. It deprives consumers of important information regarding a product, because we’ve decided that many of the following purported age-related issues are diseases, including, prediabetes, metabolic syndrome osteoarthritis, obesity, BPH, prehypertension, and, yes, even diabetes and hypertension that do not require medication to control. A natural topical product cannot even say “soothes diaper rash” if it doesn’t contain one of the enumerated topical OTC drugs for the treatment of diaper rash. Yet, products making these claims are readily available on the Internet. Many of them are legitimate yet others are sold by unscrupulous marketers that prey on the ignorance of consumers and stay ahead of federal and state agencies while creating a substantial stain on the natural products industry.

    Unfortunately, we have developed a regulatory system that fails to recognize that natural medicine helps individuals whether the product is ingested or applied topically. Instead, we have created a system that demands expensive clinical trials for ingredients that are no longer patentable because their uses are not novel, making it unlikely such a trial will be conducted. It is a system in which courts are now allowing plaintiff attorneys to file lawsuits under state deceptive trade practices if a particular structure/function or cosmetic claim might be considered a disease claim based on the preamble to a final rule or an FDA warning letter. This is true even if the company receiving the warning letter has a legitimate position that the claim is not an impermissible disease claim.

    Examples include “helps alleviate sore joints” and “helps alleviate nighttime trips in men over the age of 50” in which both claims are related to the natural progression of age. The central fact here is that as we age, our joints ache. It is part of life, but we treat it as if it were a disease. For men over 50, getting up once or twice nightly is not uncommon, and is part of the well-accepted fact that prostates grow at this stage in life. Yet, it is perceived as a disease. It is a system that has not kept up with what the public wants and legitimate companies can provide. 

    Innovation and legitimate products have become beholden to the constraints of the regulatory system and a heavy reliance on lawyers to bend and twist words to help communicate the real purpose of the product without running afoul of the system. It has created a vast number of gray areas between what is and what is not a permissible claim. We use claims such as “helps support blood pressure already in the normal range” when, in fact, if you have 120/80 blood pressure you do not need this product. However, if you are pre-hypertensive or at stage 1 where dietary intervention and exercise is always the initial intervention, including use of targeted dietary supplements that can help lower blood pressure sensitive to dietary intervention, this claim cannot be communicated to consumers by a company.

    Probably, the more absurd situation I alluded to previously is topical natural products that cannot even make the claim “helps soothe diaper rash” unless it contains specific permitted active ingredients covered by the OTC Drug Monograph system. This makes little sense and is a waste of FDA’s enforcement time to take issue with such products, especially if the claims are substantiated.

    Suggestions for Positive Disruption
    By now you are asking, “How does this relate to the disruptive results of the national election?  Todd, we know the regulatory system is screwed up and it’s not, necessarily, the fault of the regulators.” My point is that for the first time in a very long time, we have an administration that is open to true, positive disruption, and the industry should be thinking how to put a more sane regulatory system in place for both dietary supplements and topical natural products.

    We could create a natural product monograph system and specifically preclude class action lawsuits on claims that are consistent with that monograph. For those products that don’t fit into the monograph, there should be the option to conduct a clinical study on the product, and if the results are positive, the claims should be permissible. We could setup a 510k-like system, as we currently have for medical devices, but for natural products. FDA could review the study and agree whether the study supports the claim. Within this system, we could create a process in which FDA reviews the protocol of the study first (for a reasonable fee), provides feedback, and ultimately signs off on the study design.

    It should not be required to undergo the protocol review process, but if undertaken it is conducted at the company’s own risk, as medical devices do today. Clearly, however, I’m not advocating for the dismantling of DSHEA. Those who are happy with it may continue down that path. Rather, this is a system that could be in addition to DSHEA for those companies desiring to make truthful and non-misleading claims for age-related health conditions and diseases.

    Regardless, there is one amendment to DSHEA we should all agree on. This is to reset the grandfathered date for ingredients under DSHEA; the amendment would require FDA to promulgate a list within one year based on labels provided by the industry. In addition, this amendment should clarify that synthetic botanicals that are truly synthetic versions of natural constituents are permissible dietary ingredients.  

    Finally, we should also revise the civil investigation rules for the FTC to require it to disclose in detail why it believes a company’s claims are not substantiated prior to seeking an action. It should also provide the company adequate time to respond directly to the commissioners tasked with the responsibility of deciding whether to move forward should the company decide not to settle.  

    These few suggestions are not intended to be all encompassing. Rather, they’re intended to be food for thought on how we may bring about disruptive legislation that would actually improve the regulatory framework and benefit American consumers. We have at least two years for out-of-the-box thinking. The question here lays in whether the industry is ready to be disruptive by proposing disruptive legislation that makes sense and will benefit everyone. 


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Functional Food
    • DSHEA
    • Diabetes
    • Metabolic Syndrome
    Related Knowledge Center
    • Dietary Supplements
    • Healthcare Trends
    • Regulations
    • Quality & Safety
    Suggested For You
    State of the Industry Part 2: Supplement Access, Safety, and CBD State of the Industry Part 2: Supplement Access, Safety, and CBD
    One Hemp Coalition Forms to Advocate for CBD Regulatory Standards One Hemp Coalition Forms to Advocate for CBD Regulatory Standards
    AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD
    Stakeholders Demand Action on CBD at House Subcommittee Hearing Stakeholders Demand Action on CBD at House Subcommittee Hearing
    Shaping and Leading an Industry without a Clear Regulatory Framework Shaping and Leading an Industry without a Clear Regulatory Framework
    CBD Innovation and Regulation in Canada: Background, Landscape, and the Future CBD Innovation and Regulation in Canada: Background, Landscape, and the Future
    CBD MarketWatch 2023: FDA Claims New Regulatory Pathway Needed for CBD CBD MarketWatch 2023: FDA Claims New Regulatory Pathway Needed for CBD
    House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients
    CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway? CBD Expectations: What Happens at FDA and Congress After Agency Seeks New Regulatory Pathway?
    Regulatory Challenges Persist for Dietary Supplement Stakeholders Regulatory Challenges Persist for Dietary Supplement Stakeholders
    Is It Time for a ‘New FDA’ to Regulate Food and Dietary Supplements? Is It Time for a ‘New FDA’ to Regulate Food and Dietary Supplements?
    Ingestible Beauty Arrives in China Ingestible Beauty Arrives in China
    Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    Pharmactive Enters Partnership with Nutraconnect for APAC Sales Pharmactive Enters Partnership with Nutraconnect for APAC Sales
    Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized

    Related Features

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations | Weight Management/Weight Loss
      State of the Industry Part 2: Supplement Access, Safety, and CBD

      State of the Industry Part 2: Supplement Access, Safety, and CBD

      State and federal regulators have taken aim at certain products and ingredients.
      By Sean Moloughney, Editor 12.04.23

    • Breaking News | Herbs & Botanicals | Industry & Market News | Regulations
      One Hemp Coalition Forms to Advocate for CBD Regulatory Standards

      One Hemp Coalition Forms to Advocate for CBD Regulatory Standards

      The coalition of CBD stakeholders plans to advocate for CBD to be regulated as a dietary ingredient with a set of unique testing and labeling standards.
      11.30.23

    • Breaking News | Herbs & Botanicals | Quality & Safety | Regulations | Regulatory News
      AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD

      AHPA, UNPA, CHPA Respond to Congress’ Information Request on CBD

      The three organizations jointly outlined why existing regulatory frameworks are sufficient to regulate CBD-containing dietary supplements.
      08.23.23


    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      Stakeholders Demand Action on CBD at House Subcommittee Hearing

      Stakeholders Demand Action on CBD at House Subcommittee Hearing

      Advocates vocal about FDA inaction and call for quick resolution.
      By Mike Montemarano, Associate Editor 08.08.23

    • Cosmeceuticals / Nutricosmetics | Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      Shaping and Leading an Industry without a Clear Regulatory Framework

      Shaping and Leading an Industry without a Clear Regulatory Framework

      How do companies raise the bar for safety and quality while investing in research and innovation without well-defined federal guidance?
      By Sean Moloughney, Editor 04.13.23

    Loading, Please Wait..
    Breaking News
    • Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    • FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    • MSM Linked to Improvements in Knee Pain
    • Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress
    • NutraShure Introduces SA3X as Exclusive US Supplier
    View Breaking News >
    CURRENT ISSUE

    December 2023

    • State of the Industry Series (Part 1): FDA Restructuring and FTC Activity
    • State of the Industry Part 2: Supplement Access, Safety, and CBD
    • State of the Industry Part 3: Communication, Education, and Trust
    • State of the Industry Part 4: Advanced/Advancing Technologies and Research
    • State of the Industry Part 5: Advocating Best Practices
    • State of the Industry Part 6: Business Trends and Innovation
    • Radicle Science Aims to Set New Trajectory for Healthcare with Modern Clinical Trial Model
    • How Can the Nutraceuticals Industry Empower More Women?
    • The Naturally Proud Network: Supporting Diversity, Equity, and Inclusion
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    MSM Linked to Improvements in Knee Pain
    Coatings World

    Latest Breaking News From Coatings World

    INEOS Completes Acquisition of Eastman's Acetic Acid Plant in Texas
    DuPont Co-Launches PVF Coating Solution with Nippon Paint
    PPG Brings PPG MOONWALK Automated Paint Mixing System to Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    AdvaMed Names GE HealthCare Leader Peter J. Arduini as Chairman
    Hologic Promotes Essex D. Mitchell to COO
    Medtronic, Cosmo Pharmaceuticals Fortify AI-Driven Endoscopy Partnership
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ferring, PharmaBiome Partner on Microbiome R&D
    Electra Therapeutics Names Kathy Dong President and CEO
    Hummingbird Bioscience Names Angèle Maki Chief Business Officer
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Selena Gomez’s Rare Beauty Expands into Scented Body Care Category
    Peach Fuzz is Pantone’s Color of the Year 2024
    Class Action Lawsuit Filed Against The Estée Lauder Companies on Behalf of Investors
    Happi

    Latest Breaking News From Happi

    Safa’s Lavender Oil Nourishes Skin, Hair and Nails
    CIDP Upscales Capacity For Testing Sun Care Products Under Real Condition of Use
    Univar Solutions Named To Newsweek’s Most Responsible Companies List
    Ink World

    Latest Breaking News From Ink World

    INEOS Concludes Acquisition of Eastman's Acetic Acid Plant in Texas
    Solvay Concludes Syensqo Spin-off
    Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Analyzing the Russian label market, Cartes boosts brands and more
    FLAG’s December Lunch & Learn to feature Omet
    UPM Raflatac releases neuromarketing study findings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Autoneum Offers Propylat Sustainable Acoustic Technology
    Ahlstrom Announces Change to Board
    Partners Group Acquires Velvet Care
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OssDsign Realigning its Strategy to Focus on Orthobiologics
    ODT's Most-Read Stories This Week—Dec. 9
    Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Earns Highest Score on CEI
    SEMI Applauds Advancement of US Chips Act Incentives
    Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login